Trials / Completed
CompletedNCT00385658
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
A 16-week Multicenter, 2-period Study to Investigate the Effect of the Combination of Fluvastatin ER 80mg and Fenofibrate 200mg on HDL-C in Comparison to the Combination of Simvastatin 20mg and Ezetimibe 10mg in Patients With Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
This study will investigate the effects of the combination of fluvastatin and fenofibrate on dyslipidemia in comparison to the combination of simvastatin and ezetimibe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluvastatin extended release, fenofibrate | |
| DRUG | Fixed combination simvastatin/ezetimibe |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2007-03-01
- Completion
- 2007-03-01
- First posted
- 2006-10-11
- Last updated
- 2017-02-24
Locations
2 sites across 2 countries: Germany, Switzerland
Source: ClinicalTrials.gov record NCT00385658. Inclusion in this directory is not an endorsement.